ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market
In Brief: Lombardi Comprehensive Designation Renewed; Yale Plans Breast Cancer Lab
FDA News: ODAC Clears Photofrin For Microinvasive NSCLC
Report Finds NIH Not At Fault in Case Of P-32 Ingestion
Weinstein Applauds Investigation Report
Cooperative Groups: Insurers Agree To Cover Patient Care Costs In Group Trials
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Oncologist Rachna Shroff endows award to outlast her cancer diagnosis
“Because of my health, I have a profound desire to see this endowment come to fruition now” - KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Letai: MCEDs are a “great ideal”—alas, the data don’t support widespread use
“Projecting sub-ideal tests across a large population can cause harm,” Letai says, as Galleri cruises toward FDA approval - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship
